Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Biliary cirrhosis
ADR ID BADD_A06933
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.04      Hepatic fibrosis and cirrhosis
09.01.04.006      Biliary cirrhosis
Description FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. [MeSH]
MedDRA Code 10004659
MeSH ID D008105
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Biliary cirrhosis | Biliary cirrhosis NOS | Biliary cirrhosis secondary | Cirrhosis bilary | Cirrhosis biliary | Liver Cirrhosis, Biliary | Liver Cirrhoses, Biliary | Biliary Cirrhosis | Cirrhosis, Biliary | Secondary Biliary Cholangitis | Biliary Cholangitis, Secondary | Cholangitis, Secondary Biliary | Secondary Biliary Cholangitides | Secondary Biliary Cirrhosis | Cirrhosis, Secondary Biliary | Biliary Cirrhosis, Secondary | Liver Cirrhosis, Obstructive | Obstructive Liver Cirrhosis | Primary Billiary Cholangitis | Billiary Cholangitis, Primary | Cholangitis, Primary Billiary | Primary Billiary Cholangitides | Biliary Cirrhosis, Primary, 1 | Biliary Cirrhosis, Primary | Cholangitis, Chronic Nonsuppurative Destructive | Primary Biliary Cirrhosis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00100Ambrisentan0.000181%
BADD_D02392Zoledronic acid--
The 1th Page    1    Total 1 Pages